The Clopidogrel in Unstable Angina to Prevent Recurrent Events (CURE) study: To what extent should the results be generalizable?

被引：28

作者：

Gerschutz, GP ^{[1
]}

Bhatt, DL ^{[1
]}

机构：

[1] Cleveland Clin Fdn, Dept Cardiol, Cleveland, OH 44195 USA

来源：

AMERICAN HEART JOURNAL | 2003年 / 145卷 / 04期

关键词：

D O I：

10.1067/mhj.2003.180

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The Clopidogrel in Unstable Angina to Prevent Recurrent Events (CURE) study investigated the use of clopidogrel in the treatment of acute coronary syndromes. Clopidogrel treatment led to an impressive 20% relative risk reduction in the composite outcome measure of vascular death, myocardial infarction, and stroke. Increased bleeding and greater requirements for blood transfusions were seen with clopidogrel. The addition-of clopidogrel to aspirin represents a major advance in the treatment of acute coronary syndromes.

引用

页码：595 / 601

页数：7

共 35 条

[11] Reduction in the need for hospitalization for recurrent ischemic events and bleeding with clopidogrel instead of aspirin [J].

Bhatt, DL ;

Hirsch, AT ;

Ringleb, PA ;

Hacke, W ;

Topol, EJ .

AMERICAN HEART JOURNAL, 2000, 140 (01) :67-73

[12] Current role of platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes [J].

Bhatt, DL ;

Topol, EJ .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 284 (12) :1549-1558

[13] Effect of clopidogrel added to aspirin before percutaneous coronary intervention on the risk associated with C-reactive protein [J].

Chew, DP ;

Bhatt, DL ;

Robbins, MA ;

Mukherjee, D ;

Roffi, M ;

Schneider, JP ;

Topol, EJ ;

Ellis, SG .

AMERICAN JOURNAL OF CARDIOLOGY, 2001, 88 (06) :672-674

[14]

Chew DP, 2001, CIRCULATION, V103, P201

[15] A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE) [J].

Gent, M ;

Beaumont, D ;

Blanchard, J ;

Bousser, MG ;

Coffman, J ;

Easton, JD ;

Hampton, JR ;

Harker, LA ;

Janzon, L ;

Kusmierek, JJE ;

Panak, E ;

Roberts, RS ;

Shannon, JS ;

Sicurella, J ;

Tognoni, G ;

Topol, EJ ;

Verstraete, M ;

Warlow, C .

LANCET, 1996, 348 (9038) :1329-1339

[16] MULTICENTER INVESTIGATION OF CORONARY STENTING TO TREAT ACUTE OR THREATENED CLOSURE AFTER PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY - CLINICAL AND ANGIOGRAPHIC OUTCOMES [J].

GEORGE, BS ;

VOORHEES, WD ;

ROUBIN, GS ;

FEARNOT, NE ;

PINKERTON, CA ;

RAIZNER, AE ;

KING, SB ;

HOLMES, DR ;

TOPOL, EJ ;

KEREIAKES, DJ ;

HARTZLER, GO .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1993, 22 (01) :135-143

[17] Profile and prevalence of aspirin resistance in patients with cardiovascular disease [J].

Gum, PA ;

Kottke-Marchant, K ;

Poggio, EC ;

Gurm, H ;

Welsh, PA ;

Brooks, L ;

Sapp, SK ;

Topol, EJ .

AMERICAN JOURNAL OF CARDIOLOGY, 2001, 88 (03) :230-235

[18] Effectiveness of aspirin and clopidogrel combination therapy in coronary stenting [J].

Jauhar, R ;

Bergman, G ;

Savino, S ;

Deutsch, E ;

Shaknovich, A ;

Parikh, M ;

Sanborn, TA .

AMERICAN JOURNAL OF CARDIOLOGY, 1999, 84 (06) :726-+

[19] A clinical trial comparing three antithrombotic drug regimens after coronary-artery stenting [J].

Leon, MB ;

Baim, DS ;

Popma, JJ ;

Gordon, PC ;

Cutlip, DE ;

Ho, KKL ;

Giambartolome, A ;

Diver, DJ ;

Lasorda, DM ;

Williams, DO ;

Pocock, SJ ;

Kuntz, RE .

NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (23) :1665-1671

[20] Multiple mechanisms of thrombosis complicating atherosclerotic plaques [J].

Libby, P .

CLINICAL CARDIOLOGY, 2000, 23 (11) :3-7

← 1 2 3 4 →